Acquired Bleeding Disorders

• CLINICAL_TRIALS trial_result · 2017-02-27
  Clinical Trial Update: Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation [Phase 2]

  A Phase 2 trial evaluating the efficacy and safety of activated recombinant human factor VII for treating bleeding after hematopoietic stem …

• CLINICAL_TRIALS trial_result · 2017-01-13
  Clinical Trial Update: Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation [Phase 2]

  Phase 2 clinical trial evaluating the safety and efficacy of activated recombinant human coagulation factor VII in patients undergoing ortho…

• CLINICAL_TRIALS trial_result · 2014-11-13
  Clinical Trial Update: Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery [Phase 2]

  Phase 2 multinational trial evaluated the effect and safety of recombinant factor XIII (rFXIII) on transfusion needs in patients undergoing …

• CLINICAL_TRIALS trial_result · 2014-01-30
  Clinical Trial Update: Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

  This completed observational study evaluates the use of NovoSeven (recombinant factor VIIa) for haemostatic treatment of bleeding episodes i…

• CLINICAL_TRIALS trial_result · 2009-11-26
  Clinical Trial Update: Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding [Phase 3]

  A Phase 3 trial of recombinant coagulation factor VIIa in patients with severe bleeding was terminated; results were posted in 2009.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.